| scholarly article | Q13442814 |
| P50 | author | Colin Jacobs | Q53006685 |
| Bram van Ginneken | Q58101398 | ||
| Sarah J van Riel | Q89868602 | ||
| Ernst T Scholten | Q94562831 | ||
| Francesco Ciompi | Q110077661 | ||
| Matiullah Naqibullah | Q117279457 | ||
| Mathilde M Winkler Wille | Q117279458 | ||
| P2093 | author name string | Stephen Lam | |
| Cornelia Schaefer-Prokop | |||
| Mathias Prokop | |||
| P2860 | cites work | Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines | Q27025828 |
| Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach | Q29614698 | ||
| Probability of cancer in pulmonary nodules detected on first screening CT. | Q30573941 | ||
| Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada | Q30587070 | ||
| Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening | Q30857368 | ||
| Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening | Q34723975 | ||
| CT Screening for Lung Cancer: Nonsolid Nodules in Baseline and Annual Repeat Rounds | Q36232460 | ||
| Nodular ground-glass opacities on thin-section CT: size change during follow-up and pathological results | Q37061917 | ||
| National lung screening trial: variability in nodule detection rates in chest CT studies | Q37113252 | ||
| Screening for lung cancer using low dose computed tomography | Q38215277 | ||
| Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling | Q41199112 | ||
| Predictive Accuracy of the PanCan Lung Cancer Risk Prediction Model -External Validation based on CT from the Danish Lung Cancer Screening Trial | Q41237900 | ||
| Development of Guidelines for the Management of Pulmonary Nodules: Toward Better Implementation | Q43147625 | ||
| British Thoracic Society guidelines for the investigation and management of pulmonary nodules. | Q51621075 | ||
| Persistent pulmonary subsolid nodules with solid portions of 5 mm or smaller: Their natural course and predictors of interval growth. | Q52990832 | ||
| Observer Variability for Classification of Pulmonary Nodules on Low-Dose CT Images and Its Effect on Nodule Management. | Q53006595 | ||
| Management of lung nodules detected by volume CT scanning. | Q53321287 | ||
| Critique of Al-Ameri et al. (2015) - Risk of malignancy in pulmonary nodules: A validation study of four prediction models | Q85370239 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2017-03-14 | |
| P1433 | published in | European Radiology | Q5413071 |
| P1476 | title | Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines |
| Q49202631 | Advances in intelligent diagnosis methods for pulmonary ground-glass opacity nodules |
| Q88034408 | Applying Risk Prediction Models to Optimize Lung Cancer Screening: Current Knowledge, Challenges, and Future Directions |
| Q47689794 | European position statement on lung cancer screening |
| Q90090384 | External validation of a convolutional neural network artificial intelligence tool to predict malignancy in pulmonary nodules |
| Q92273035 | Insights for Management of Ground-Glass Opacities From the National Lung Screening Trial |
| Q64957193 | Lung cancer screening: nodule identification and characterization. |
| Q44770720 | Malignancy risk estimation of pulmonary nodules in screening CTs: Comparison between a computer model and human observers |
| Q89503752 | Protocol and Rationale for the International Lung Screening Trial |
| Q64914470 | Quantitative Imaging features Improve Discrimination of Malignancy in Pulmonary nodules. |
| Q93002175 | Validated imaging biomarkers as decision-making tools in clinical trials and routine practice: current status and recommendations from the EIBALL* subcommittee of the European Society of Radiology (ESR) |
| Q55278957 | Validation of prediction models for risk stratification of incidentally detected pulmonary subsolid nodules: a retrospective cohort study in a Korean tertiary medical centre. |
Search more.